Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists Develop Technique that can Tell if Drugs Have Hit Their Target in the Human Body

Published: Monday, July 22, 2013
Last Updated: Monday, July 22, 2013
Bookmark and Share
The search for new drugs, including those for cancer, is set to speed up thanks to a new research technique invented by scientists at the Nanyang Technological University (NTU).

Named the “Cellular Thermal Shift Assay” (CETSA), scientists can now know for sure if a drug had reached its target protein in the body, which is a critical step in determining the effectiveness of most medicines.

Presently, scientists can only hypothesise if a drug has indeed reached its target protein, leading to expensive and prolonged drug development process. CETSA will help scientists take out much of the usual trial-and-error guesswork from the drug development equation.

This research breakthrough was recently published in Science, one of the world’s top scientific journals.

Most drugs operate by binding to one or more proteins, which ‘blocks’ the proteins’ function. Scientists around the world face two common bottlenecks: how to identify the right proteins to target and how to design drug molecules which are able to efficiently seek out and bind to these proteins.

CETSA’s inventor, Professor Pär Nordlund from NTU’s School of Biological Sciences, said their new method will not only ease the two bottlenecks, but also has important applications in monitoring a patient’s progress, for example, during cancer treatment.

“With CETSA, we can in principle determine which drug and treatment regime is most effective at targeting the proteins in the tumour in cancer patients, and monitor when resistance is developing,” says Prof Nordlund.

How CETSA works

When drugs react with target proteins in a cell, the proteins are able to withstand higher temperature before unfolding and precipitating, that is, turning solid. An example of protein precipitation is when liquid egg white (which is protein) is cooked (turning solid) at high heat.

“By heating protein samples and finding out which proteins are ‘cooked’ and which are left ‘uncooked’ due it being more heat resistant, we are able to know if the drugs had reached their target cells and if it had caused the desired binding to the proteins, blocking its functions,” added Prof Nordlund, who is also a Professor of Biophysics at the Karolinska Institutet, one of Europe's most prestigious medical universities, located in Sweden.

“With CETSA, costly and challenging drug development cycles can potentially be made more efficient, as the method can be used as a stringent control step at many phases of the process. Other methods are available for indirect measurements of drug binding but they are often less accurate, and CETSA will be a valuable tool to complement these technologies,” said the Swedish professor.

This project took Prof Nordlund’s team three years and they are now in the process of developing a prototype device. They are also in talks with pharmaceutical companies who are interested to collaborate in research.

Prof Nordlund is a leading structural biologist instrumental in establishing the laboratory of the Structural Genomics Consortium at Karolinska Institutet (Stockholm), and had received the prestigious Göran Gustafsson prize in chemistry from the Swedish Academy of Sciences in 2001.

He is also a member of the Nobel Assembly at the Karolinska Institutet and the Chemistry Class at the Swedish Academy of Science, as well as a Reviewing Editor at Science Magazine. In addition, he is the co-founder of three biotech companies Evitra Proteoma, Sprint Biosciences and Pelago Bioscience.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
Teeth Reveal Lifetime Exposures to Metals, Toxins
Researchers have identified dental biomarkers to reveal links between early iron exposure and late life brain diseases.
An Innovative Algorithm to Decipher How Drugs Work Inside the Body
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
Uncovering the Spread of Bacteria in Pneumonia
Northwestern Medicine scientists have discovered the role a toxin produced by a pneumonia-causing bacterium plays in the spread of infection from the lungs to the bloodstream in hospitalized patients.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
Rare Form: Novel Structures Built from DNA Emerge
DNA, the molecular foundation of life, has new tricks up its sleeve. The four bases from which it is composed can be artificially manipulated to construct endlessly varied forms in two and three dimensions.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!